Patheon Puerto Rico, Inc. submitted a proposal to the Foreign-Trade Zones (FTZ) Board on September 2, 2020, for production activities at its facility in ManatΓ, Puerto Rico. This notification followed the regulations of the FTZ Board and was open for public comment. On December 31, 2020, the FTZ Board decided that no further review was required and authorized the production activities. This decision complies with the FTZ Act and the FTZ Board's regulations.
Simple Explanation
The government said it's okay for a company in Puerto Rico called Patheon to make medicine at their factory, and they checked some rules to make sure everything is alright.